However, several targeted therapies have recently been developed for potentially actionable alterations, including BRAF and human epidermal growth factor receptor 2 (HER2) oncogenes, advancing the ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations ...
Among more than 7.8 million CRC screenings, the share of patients aged 45 to 49 years jumped from 2.9% before the guideline changes to 17.8% afterward. The average monthly screenings for this younger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback